Which medication is noted for having secondary metabolism by the kidney?

Which medication is noted for having secondary metabolism by the kidney?

• A. Sevoflurane
• B. Thiopental
• C. Propofol
• D. Isoflurane

Answer: (A)

Sevoflurane is an inhalational anesthetic that undergoes metabolism primarily in the liver; however, a significant aspect of its pharmacokinetics is its secondary metabolism via the kidneys. When sevoflurane is metabolized, it produces a compound known as hexafluoroisopropanol (HFIP), which is eventually excreted by the kidneys. This metabolic pathway highlights the importance of renal function in the overall elimination process for sevoflurane, making it particularly noteworthy among anesthetics. In contrast, the other medications listed, such as thiopental, propofol, and isoflurane, primarily rely on hepatic metabolism or possess different metabolic pathways with minimal involvement of the kidneys for excretion. This distinguishes sevoflurane as the only agent in this group that notably engages the kidneys in its secondary metabolic pathway. Understanding these pharmacokinetic characteristics is critical for managing patients with varying levels of renal function, ensuring safe and effective anesthesia.

Sevoflurane is an inhalational anesthetic that undergoes metabolism primarily in the liver; however, a significant aspect of its pharmacokinetics is its secondary metabolism via the kidneys. When sevoflurane is metabolized, it produces a compound known as hexafluoroisopropanol (HFIP), which is eventually excreted by the kidneys. This metabolic pathway highlights the importance of renal function in the overall elimination process for sevoflurane, making it particularly noteworthy among anesthetics.

In contrast, the other medications listed, such as thiopental, propofol, and isoflurane, primarily rely on hepatic metabolism or possess different metabolic pathways with minimal involvement of the kidneys for excretion. This distinguishes sevoflurane as the only agent in this group that notably engages the kidneys in its secondary metabolic pathway. Understanding these pharmacokinetic characteristics is critical for managing patients with varying levels of renal function, ensuring safe and effective anesthesia.